RAMP Act

HR4669 — FEMA Act of 2025

FEMA becomes an independent, cabinet-level agency with a clarified all-hazards mission and consolidated federal leadership for preparedness, response, recovery, mitigation, and interoperable communications. The bill also rewrites large parts of the Stafford Act to speed repairs, expand assistance, strengthen mitigation, and publish new public dashboards for disaster spending and individual aid metrics. - Families and disaster survivors: Expands housing help with a FEMA Emergency Home Repair program, authorizes direct repair assistance, and extends some temporary assistance periods from 18 to 24 months. Noncongregate sheltering can be provided without a fixed address and states cannot require a credit card for hoteling. - State, Tribal, and local governments and utilities: Creates expedited Section 409 grants for repairing public and qualifying nonprofit facilities with a Federal share floor of 75% and incentives up to 85% for resilience. Offers small-disaster block grants equal to 80% of the estimated Federal public assistance share and sets a Tribal hazard-mitigation minimum of $75.0 million per year. - Private nonprofits and houses of worship: Treats private nonprofits and houses of worship as eligible for assistance without regard to religious character and expands nonprofit closeout and eligibility parity with governments.

HR6900 — American Affordability Act of 2025

This bill would be a broad tax-credit overhaul that rewrites incentives across housing, families, and clean energy. It would create monthly child payments, reshape housing tax programs, and add new investment credits for recycling, transmission, and batteries. - Families, children, and caregivers: It would create a monthly Child Tax Credit of $300 for children 6 and older and $360 for those under 6, with a portal and presumptive eligibility rules. It would also raise the Child and Dependent Care Tax Credit rates to 50% and increase qualifying expense limits to $8,000 single and $16,000 per family. - Renters, homebuyers, and developers: It would change Low‑Income Housing Tax Credit rules, repeal the qualified contract option for most buildings, and create new housing incentives including an Affordable Housing Conversion Credit with program caps described that include $12.0 billion and a separate $3.0 billion AHCC designation program. - Clean energy, transport, and industry: It would extend many clean energy and clean vehicle credits and add new investment credits that are generally 30%. It would authorize a $3.0 billion advanced battery credit allocation and create credits for water reuse, recycling, and transmission line projects.

HR1229 — United States-Israel Defense Partnership Act of 2025

Would deepen U.S.-Israel defense cooperation by creating new joint programs, offices, and multi-year funding to develop and deploy counter-unmanned systems and other emerging defense technologies. - U.S. military and Department of Defense: Creates a United States–Israel Counter-Unmanned Systems Program and a program office, authorizes $150 million per year for 2026–2030, and requires annual unclassified reports. - U.S. and Israeli defense industries and tech firms: Authorizes joint research, testing, and procurement across artificial intelligence, cybersecurity, robotics, quantum, and automation with $50 million per year for 2026–2030 and a framework for cost sharing and intellectual property. - Regional partners and missile defense planners: Requires an assessment of integrated air and missile defense in the U.S. Central Command area with an unclassified report in 180 days and extends the War Reserves Stockpile Authority beyond January 1, 2029. Would authorize $150 million per year for counter-unmanned systems and $50 million per year for emerging technology cooperation from 2026–2030, and raises funding caps for anti-tunnel and counter-UAS programs through 2028.

HR1518 — New Era of Preventing End-Stage Kidney Disease Act

Preventing end-stage kidney disease by creating NIDDK Centers of Excellence that fund research, expand provider and public education, and reach rural and underserved communities to better diagnose and treat rare kidney diseases. - Researchers and clinicians: Establishes NIDDK Centers of Excellence on Rare Kidney Disease Research and funds grants and cooperative agreements to study causes, symptoms, diagnosis, progression, and treatments, including genotype‑phenotype relationships. It bars use of QALYs, DALYs, or similar measures that discriminate against people with disabilities in value assessments. - Patients and families: Permits centers to cover patient care costs needed for research and to provide education on diagnosis, routine urinalysis, genetic testing, renal diet, and mental and emotional health resources. The bill emphasizes outreach and information programs for rural and underserved communities and people diagnosed with rare kidney diseases. - Health systems and federal coordination: Supports clinical training, continuing education, and demonstration projects for diagnostic, prevention, control, and treatment methods and requires coordination with other NIH institutes and the FDA. Each center may receive up to 5 years of support with possible 5‑year extensions under peer review, and the bill authorizes $6 million per year for FY2026–2030 to carry out these activities. If enacted, this bill would authorize $6 million per year for FY2026–2030, increasing federal spending by about $30 million over that five-year period.

HR1262 — Mikaela Naylon Give Kids a Chance Act

Speeds and strengthens pediatric cancer drug development. It expands which cancer products companies must study in children, reshapes organ transplant network governance and fees, and adds new FDA international and transparency steps. - Children with cancer and researchers: Requires pediatric studies that produce clinically meaningful data on dosing, safety, and early effectiveness and widens the kinds of drug combinations studied. It also sets aside $25 million for pediatric drug studies in each of fiscal years 2026, 2027, and 2028. - Transplant patients and transplant network members: Changes Organ Procurement and Transplantation Network governance and financing by allowing quarterly registration fees, requiring those fees fund OPTN operations, improving electronic health record integration, and calling for a GAO review within two years. - FDA partners and drug makers: Creates an Abraham Accords Office to boost regulatory coordination and technical assistance abroad, and forces more transparency during generic (ANDA) reviews about whether generics are qualitatively and quantitatively the same as listed drugs. It also raises the Medicare Improvement Fund amount from $1.4 billion to $2.6 billion. Increases federal outlays by roughly $1.3 billion, driven by a $1.2 billion boost to the Medicare Improvement Fund and $75 million for pediatric studies, adding to federal spending.

HR5343 — Ensuring Patient Access to Critical Breakthrough Products Act

This bill would create a structured, four-year pathway that gives Medicare special, time-limited coverage for FDA-designated breakthrough medical devices. Coverage during that transition is tied to following FDA-approved labeling or to a Secretary review that the device's benefits outweigh its risks. - Medicare beneficiaries: Seniors and other people on Parts A and B would have a defined four-year window of transitional coverage for devices the FDA designates as breakthrough. Coverage depends on using the device as labeled or on a Secretary risk-benefit finding. - Device manufacturers: Manufacturers can seek a breakthrough designation starting 18 months after enactment and would get a decision within six months of application. A designation triggers the four-year transitional coverage period and faster coverage review timelines. - CMS and providers: CMS must report annually on applications and designations and may review providers with unusual billing for these devices to protect program integrity. The Secretary must issue final national coverage decisions within set deadlines so decisions finish during the transition when requests meet timing rules. This bill would increase federal spending by $10 million per year from fiscal 2025 through 2030, about $60 million total, to fund CMS implementation and oversight.